Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) – Research analysts at B. Riley decreased their FY2024 earnings per share (EPS) estimates for shares of Celsius in a note issued to investors on Wednesday, November 6th. B. Riley analyst J. Van. Sinderen now anticipates that the company will post earnings of $0.59 per share for the year, down from their prior forecast of $0.65. B. Riley currently has a “Buy” rating and a $47.00 price objective on the stock. The consensus estimate for Celsius’ current full-year earnings is $0.74 per share. B. Riley also issued estimates for Celsius’ Q4 2024 earnings at $0.03 EPS and FY2026 earnings at $1.01 EPS.
Several other research analysts have also recently weighed in on CELH. Bank of America dropped their price target on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research note on Thursday, September 5th. Maxim Group lowered their target price on Celsius from $65.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, September 5th. Jefferies Financial Group reduced their price target on Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research report on Thursday, October 10th. Morgan Stanley reaffirmed an “equal weight” rating and set a $50.00 price objective on shares of Celsius in a research report on Tuesday, August 20th. Finally, UBS Group reduced their target price on shares of Celsius from $50.00 to $45.00 and set a “buy” rating for the company in a report on Thursday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $54.40.
Celsius Trading Down 3.7 %
CELH opened at $28.90 on Friday. The company’s 50 day moving average is $32.15 and its 200 day moving average is $51.06. The company has a market cap of $6.79 billion, a price-to-earnings ratio of 40.14, a PEG ratio of 2.51 and a beta of 1.86. Celsius has a 12-month low of $27.78 and a 12-month high of $99.62.
Institutional Trading of Celsius
A number of large investors have recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA grew its holdings in shares of Celsius by 231.2% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after purchasing an additional 2,754,722 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Celsius by 18.7% during the 1st quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock valued at $1,352,737,000 after buying an additional 2,567,290 shares in the last quarter. Capital International Investors lifted its holdings in shares of Celsius by 50.6% in the 1st quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock valued at $328,877,000 after acquiring an additional 1,333,217 shares during the last quarter. Capital Research Global Investors purchased a new position in Celsius in the first quarter worth about $99,746,000. Finally, GQG Partners LLC bought a new stake in Celsius during the first quarter worth approximately $76,352,000. Institutional investors own 60.95% of the company’s stock.
Insider Buying and Selling
In other Celsius news, CEO John Fieldly sold 74,847 shares of Celsius stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total value of $2,454,981.60. Following the sale, the chief executive officer now directly owns 1,812,490 shares in the company, valued at approximately $59,449,672. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.20% of the stock is owned by company insiders.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Further Reading
- Five stocks we like better than Celsius
- Top Stocks Investing in 5G Technology
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 11/4 – 11/8
- 10 Best Airline Stocks to Buy
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.